http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005079181-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20
filingDate 2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca7d5e6e70b25736876676e5a088c572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2f2e33f97cb561d0c8c728e654e686e
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005079181-A1
titleOfInvention Use of immunoglobulins from egg yolk to treat infections caused by parasites both in animals and in humans
abstract This invention is related to the use of immunoglobulins obtained from the egg yolk of hens hyperimmunized with a mixture of oocysts from several Eimerias species, but can be extended to any human or animal parasites. The immunoglobulins are obtained through the aqueous phase extraction of egg yolk through the use of hydroxypropylmethylcellulose phtalate at a final concentration of 0.05% and sodium azide at a final concentration of 0.001% as preservative. This invention is related also to the administration of said immunoglobulins in powder form in the food at a rate of 0.5 kg per ton of finished food. The administration of immunoglobulins both in liquid as well as in powder form lowers mortality, lesions and counts of coccidian oocysts in treated animals. On the other hand, the use of immunoglobulins produces weight gain in the treated animals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008065973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008082915-A1
priorityDate 2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5311841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5753228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6217865-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807551-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499051
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5804
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68595
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33557
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID51314
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226959278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129887459
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453724736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451936144
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5802
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID51314

Total number of triples: 39.